Ibrutinib induced sensorimotor neuropathy: A novel side effect

Authors : Disha Tiwari, Dipanjan Panda, Atul Sharma, Dewesh Kishan

DOI : 10.18231/j.ijpo.2023.035

Volume : 10

Issue : 2

Year : 2023

Page No : 174-176

Chemotherapy-induced peripheral neuropathy (CIPN) is a well-documented toxicity leading to dose limitation.Ibrutinib is an oral Bruton’s Tyrosine Kinase (BTK) inhibitor approved for treating chronic lymphocytic lymphoma. The most common neurological side effects of Ibrutinib include headache and dizziness. Herein, we report peripheral neuropathy as a dose-limiting manifestation of Ibrutinib treatment.

Keywords: Chemotherapy­induced, Ibrutinib, Sensorimotor neuropathy, CLL, Side effect.


Citation Data